EquityFlowCompanies › Lumicks

Lumicks

Biotech · Amsterdam, NL · lumicks.com

Single-molecule and cell-avidity analysis instruments

Funding history

DateRoundAmount
Apr 2021Series D Plus
Amsterdam life-science-tools company Lumicks raised a $93M Series D led by Farallon Capital and Lauxera Capital Partners, with SoftBank Vision Fund 2 and T. Rowe Price.
$93M

Investors

Farallon Capital ManagementGilde HealthcareLauxera Capital PartnersSoftBank Vision Fund 2T. Rowe Price

Similar companies in Biotech

Explore funding flow on EquityFlow →